Treatment Response in Children with Relapsing MOGAD.

This article, published in the journal Neuropediatrics, discusses the treatment response in children with relapsing MOG-associated disease (MOGAD). The study evaluated the use of intravenous immunoglobulins (IVIG) compared to other therapies in children with relapsing disease course. The results showed that the annual relapse rate (ARR) was lower in all treatment groups compared to no treatment, with the lowest ARR observed in patients treated with IVIG alone. The study suggests that IVIG may have a favorable treatment effect in relapsing MOGAD, but further research is needed to determine the optimal treatment. [Extracted from the article]